Molecular genetics of hypertrophic cardiomyopathy

Current Cardiology Reports

Volumn 2, Issue 2, 2000, Pages 134-140

  Towbin, Jeffrey A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN;

ADULT; AGED; ANIMAL; CHROMOSOME MAP; GENETICS; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW;

ADULT; AGED; ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; CHROMOSOME MAPPING; GENOTYPE; HUMANS; MICROFILAMENT PROTEINS; MUTATION; PHENOTYPE;

EID: 0034153874     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-000-0010-9     Document Type: Article

References (53)

1. Maron BJ: Hypertrophic cardiomyopathy. Lancet 1997, 350:127-133.
2. Spirito P, Seidman CE, McKenna WJ, Maron BJ: The management of hypertrophic cardiomyopathy. N Engl J Med 1997, 336:775-785.
3. Maron BJ, Gardin JM, Flack JM, et al. : Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 1995, 92:785-789.
4. Maron BJ, Spirito P, Wesley YE, Arce J: Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 1986, 315:610-614.
5. Maron BJ, Shirani J, Pollac LC, et al. : Sudden death in young competitive athletes. Clinical demographic and pathological profiles. JAMA 1996, 27:199-204.
6. Jarcho JA, McKenna W, Pare JAP, et al. : Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 1989, 321:1372-1378.
7. Brugada P, Brugada JP: Right bundle-branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992, 20:1391-1396.
8. Solomon SD, Jarcho JA, McKenna WJ, et al. : Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease. J Clin Invest 1990, 86:993-999.
9. Schwartz K, Dufour C, Fougerousse F, et al. : Exclusion of myosin heavy chain and cardiac actin gene involvement in hypertrophic cardiomyopathies of several French families. Circ Res 1992, 71:3-8.
10. Thierfelder L, MacRae C, Watkins H, et al. : A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci U S A 1993, 90:6270-6274.
11. Watkins H, MacRae C, Thierfelder L, et al. : A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nat Genet 1993, 3:333-337.
12. Carrier L, Hengstenberg C, Beckmann JS, et al. : Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nature Genet 1993, 4:311-313.
13. MacRae CA, Ghaisas N, Kass S, et al. : Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White Syndrome maps to a locus on chromosome 7q3. J Clin Invest 1995, 96:1216-1220.
14. Poetter K, Jiang H, Hassanzadeh S, et al. : Mutation in either the essential regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nature Genet 1996, 13:63-69.
15. Kimura A, Harada H, Park JE, et al. : Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nature Genet 1997, 16:379-382.
16. Mogensen J, Klausen IC, Pederson AK, et al. : a-Cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest 1999, 103:T39-R43.
17. Satho M, Takahashi M, Sakamoto T, et al. : analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene. Biochem Biophys Res Commun 1999, 262:411-417.
18. Thierfelder L, Watkins H, MacRae C, et al. : a-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994, 77:701-704.
19. Bonne G, Carrier L, Richard P, et al. : Familial hypertrophic cardiomyopathy from mutations to functional defects. Circ Res 1998, 83:380-593.
20. Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al. : A molecular basis for familial hypertrophic cardiomyopathy b-cardiac myosin heavy chain gene missense mutation. Cell 1990, 62:999-1006.
21. Watkins H, Conner D, Thierfelder L, et al. : Mutations in the cardiac myosin binding protein-C gene on chromosome cause familial hypertrophic cardiomyopathy. Nat Genet 1995, 11:434-437.
22. Bonne G, Carrier L, Bercovici J, et al. : Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995, 11:438-440.
23. Schiaffino S, Reggiani C: Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 1996, 76:371-423.
24. Vikstrom KL, Factor SM, Leinwand LA: Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med 1996, 2:556-567.
25. Geisterfer-Lowrance AA, Christie M, Conner DA, et al. : A mouse model of familial hypertrophic cardiomyopathy. Science 1996, 272:731-734.
26. Fatkin D, Christe ME, Aristizabal O, et al. : Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutant in the a-cardiac myosin heavy chain gene. J Clin Invest 1999, 103:147-153.
27. Hofmann PA, Hartzell HC, Moss R: Alterations in Ca2+ sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers. J Gen Physiol 1991, 97:1141-1163.
28. Carrier L, Bonne G, Bährend E, et al. : Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res 1997, 80:427-434.
29. Gautel M, Zuffardi O, Freiburg A, Labeit S: Phosphorylation switches specific for the cardiac isoform of myosin binding protein C: a modulator of cardiac contraction? EMBO J 1995, 14:1952-1960.
30. Fougerousse F, Delezoide AL, Fiszman MY, et al. : myosin binding protein C gene is specifically expressed in heart during murine and human development. Circ Res 1998, 82:130-133.
31. Gautel M, Fürst DO, Cocco A, Schiaffino S: Isoform transitions of the myosin-binding protein C family in developing human and mouse muscles. Lack of isoform transcomplementation in cardiac muscle. Circ Res 1998, 82:124-129.
32. McConnell BK, Jones KA, Fatkin D, et al. : Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest 1999, 104:1235-1244.
33. Yang Q: A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J Clin Invest 1998, 102:1292-1300.
34. Lees-Miller JP, Helfman DM: The molecular basis for tropomyosin isoform diversity. Bioessays 1991, 13:429-437.
35. Mesnard L, Logeart D, Taviaux S, et al. : Human cardiac troponin T: cloning and expression of new isoforms in the normal and failing heart. Circ Res 1995, 76:687-692.
36. Townsend P, Barton P, Yacoub M, Farza H: Molecular cloning of human cardiac troponin T isoforms: expression in developing and failing heart. J Mol Cell Cardiol 1995, 27:2223-2236.
37. Forissier JF, Carrier L, Farza H, et al. : Codon 102 of the cardiac troponin T gene is a putative hot sot for mutations in familial hypertrophic cardiomyopathy. Circulation 1996, 94:3069-3073.
38. Farza H, Townsend PJ, Carrier L, et al. : Genomic organisation, alternative splicing and polymorphisms of the human cardiac troponin T gene. J Mol Cell Cardiol 1998, 3:1247-1253.
39. Hunkeler NM, Kullman J, Murphy AM: Troponin I isoform expression in human heart. Circ Res 1991, 69:1409-1414.
40. Solaro RJ, Van Eyk J: Altered interactions among thin filament proteins modulate cardiac function. J Mol Cell Cardiol 1996, 28:217-230.
41. Olson T, Michels VV, Thibodeau SN, et al. : Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998, 280:750-752.
42. Watkins H, Rosenzweig T, Hwang DS, et al. : Characteristic and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992, 326:1106-1114.
43. Watkins H, McKenna WJ, Thierfelder L, et al. : Mutations in the genes for cardiac Troponin T and a-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995, 332:1058-1064.
44. Moolman JC, Corfield VA, Posen B, et al. : Sudden death due to troponin T mutations. J Am Coll Cardiol 1997, 29:549-555.
45. Nimura H, Bachinski LL, Sangwatanaroh S, et al. : Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998, 33:1248-1257.
46. Charron P, Dubourg O, Desnos M, et al. : Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to cardiac myosin binding protein C gene. Circulation 1998, 97:2230-2236.
47. Marian AJ, Yu Q-T, Workman R, et al. : Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993, 342:1085-1086.
48. Yonega K, Okamoto H, Machida M, et al. : Angiotensinconverting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am Heart J 1995, 130:1089-1093.
49. Tesson F, Dufour C, Moolman JC, et al. : The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol 1997, 29:831-838.
50. Towbin JA, Lipshultz SE: Genetics of neonatal cardiomyopathy. Curr Opin Cardiol 1999, 14:250-262.
51. Mott AR, Pac F, Denfield SW, et al. : Hypertrophic cardiomyopathy in children. J Am Coll Cardiol 2000, in press.
52. Towbin JA: The role of cytoskeletal proteins in cardiomyopathies. Curr Opin Cell Biol 1998, 10:131-139.
53. Towbin JA, Bowles KR, Bowles NE: Etiologies cardiomyopathy and heart failure. Nat Med 1999, 5:266-267.